NCT07107490 2026-02-06A PHASE I STUDY OF ALPS12 IN PATIENTS WITH EXTENSIVE STAGE SMALL CELL LUNG CANCERChugai PharmaceuticalPhase 1 Recruiting122 enrolled
NCT04699838 2026-01-02Chemo-Immunotherapy Followed by Durvalumab and Ceralasertib in Treatment Naïve Patients With Extensive Stage Small Cell Lung CancerBig Ten Cancer Research ConsortiumPhase 2 Recruiting30 enrolled